Caroline Loew
Net worth: 892 815 $ as of 2024-04-29
Profile
Caroline J.
Loew is currently the President, Chief Executive Officer & Director at Mural Oncology Plc.
Previously, she served as the Chief Executive Officer & Director at Glympse Bio, Inc. from 2018 to 2022 and as the Vice President & Head-Research at Bristol-Myers Squibb Co. from 2015 to 2018.
Dr. Loew obtained her undergraduate and doctorate degrees from Imperial College London.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
1.49% | 2024-02-29 | 252,922 ( 1.49% ) | 892 815 $ | 2024-04-29 |
Caroline Loew active positions
| Companies | Position | Start |
|---|
Former positions of Caroline Loew
| Companies | Position | End |
|---|---|---|
Glympse Bio, Inc.
 Glympse Bio, Inc. BiotechnologyHealth Technology Glympse Bio, Inc. develops modular nanoparticle sensors to create diagnostics for diseases. It uses engineered diagnostic agents that interrogate the body for certain disease states, and then carry the message to the urine for analysis. The company was founded in 2015 by Sangeeta Bhatia and Gabe A. Kwong and is headquartered in Cambridge, MA. | Chief Executive Officer | 2022-07-31 |
Training of Caroline Loew
| Imperial College London | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Glympse Bio, Inc.
Glympse Bio, Inc. BiotechnologyHealth Technology Glympse Bio, Inc. develops modular nanoparticle sensors to create diagnostics for diseases. It uses engineered diagnostic agents that interrogate the body for certain disease states, and then carry the message to the urine for analysis. The company was founded in 2015 by Sangeeta Bhatia and Gabe A. Kwong and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Caroline Loew
